Top officials of the food and Drug Administration, including the Commissioner, mark B. McClellan, have been waging an intense effort to defeat legislation that would allow Americans to import inexpensive prescription medicines from Canada and Europe, prompting an outcry from the measure's backers.
Fda lobbying against drug Reimportation bill prompts criticism.